Le Lézard
Classified in: Health, Covid-19 virus
Subjects: PSF, AVO

Patients Need to Choose Whether to Take Hydroxychloroquine, States the Association of American Physicians & Surgeons (AAPS)


TUCSON, Ariz., May 28, 2020 In what appears to be an escalating war against the use of hydroxychloroquine (HCQ) to protect against COVID-19, permitting over-the-counter (OTC) use under an emergency Executive Order may be the only way to allow patients to protect themselves, states the Association of American Physicians & Surgeons (AAPS).

Essential workers, in meat-packing plants, package delivery, medical care, and emergency response, among others, unavoidably face exposure. And personal protective equipment (PPE) may be unavailable or inadequate, notes AAPS.

In most states, physicians and pharmacies face unprecedented barriers to prescribing HCQ for prevention or early treatment of COVID-19, AAPS notes.

AAPS points out the following:

  1. HCQ is safer than other OTC drugs, including aspirin, acetaminophen (Tylenol), diphenhydramine (Benadryl), and Plan B.
  2. HCQ or chloroquine (CQ) has been used for more than 65 years in hundreds of millions of patients, and has been available OTC in many places.
  3. No vaccine in history has been as safe.
  4. No COVID-19 vaccine is currently available, and if one is approved, it will be on the basis of rushed and limited testing.
  5. Numerous studies show that once a patient is severely ill, HCQ is unlikely to help. Neither is remdesivir or other antiviral drugs. Prevention or early treatment is key. Waiting to get a diagnostic test result, or waiting for the test to turn positive may mean missing the window of opportunity.
  6. Once in the hospital, patients lose the ability to choose their treatment.
  7. While fear of dangerous side effects is being stoked (only in COVID patients, not in lupus patients), use of HCQ in more than 300,000 older adults with multiple other illnesses showed a rate of (mostly non-fatal) cardiac rhythm disturbances attributable to the medication in only 47/100,000 users (.047%).
  8. A number of studies and the experience of many physicians show that early HCQ, especially with zinc supplements, is highly effective in preventing severe disease and hospitalization.
  9. There are no huge profits to be made from this old, cheap medication, in contrast to the billions to be made from a vaccine or new drug.

It is always advisable to consult your physician, AAPS states, but the only way to assure that powerful bureaucracies or vested interests cannot prevent patients from exercising freedom to choose is to make the drug available OTC.

The Association of American Physicians and Surgeons (AAPS) has represented physicians of all specialties in all states since 1943. The AAPS motto is omnia pro aegroto, meaning everything for the patient.

SOURCE Association of American Physicians and Surgeons (AAPS)


These press releases may also interest you

at 04:15
Cell and gene therapies represent the next great wave of therapeutic innovation and have led to the development of promising therapies worldwide. Veristat, a scientific minded clinical research organization, announced today the launch of their...

at 04:15
The COVID-19 pandemic has wreaked havoc on the global economy and threatened to undo decades of progress made in health care Health: A Political Choice ? Act Now, Together is the latest in a series of titles produced in collaboration with the World...

at 04:05
The global ketogenic diet market size is expected to reach USD 14.75 billion by 2027, according to a new report by Grand View Research, Inc., expanding at a CAGR of 5.5% from 2020 to 2027. The rising obese population across the globe is a crucial...

at 04:00
Alma, one of the top five global leaders of energy-based medical and aesthetics solutions, unveiled its new Alma Hybridtm platform today, during a worldwide LIVE launch event, which was broadcasted from a state-of-the-art studio that was built...

at 04:00
As the Southern Illinois University Edwardsville School of Nursing's (SON) continues to experience rapid enrollment growth, it is expanding and enhancing its clinical simulation learning opportunities for future nurses. In fall 2020, the SON opened...

at 03:30
F2G Ltd, a UK- and Austria-based biotech company developing novel therapies for life-threatening systemic fungal infections, announced today that the US Food and Drug Administration (FDA) has...



News published on 28 may 2020 at 16:47 and distributed by: